| 晚期肾癌免疫治疗新进展 |
| |
| 引用本文： | 王伟,张杰. 晚期肾癌免疫治疗新进展[J]. 世界临床药物, 2014, 0(2): 65-68 |
| |
| 作者姓名： | 王伟 张杰 |
| |
| 作者单位： | 武汉大学人民医院泌尿外科;湖北理工学院附属黄石中心医院 |
| |
| 摘 要： | 肾细胞癌（RCC）是泌尿系统常见的恶性肿瘤,早期可行手术根治性切除,晚期对放化疗均不敏感。随着肿瘤生物治疗的研究,晚期RCC的免疫治疗取得了许多实质性的进展。本文综述近年晚期RCC免疫治疗的临床研究进展。
|
| 关 键 词： | 肾细胞癌（RCC） 免疫治疗 靶向治疗 疫苗 |
New progress of immunotherapies for advanced renal cell cancer |
| |
| WANG Wei;ZHANG Jie. New progress of immunotherapies for advanced renal cell cancer[J]. WORLD CLINICAL DRUGS, 2014, 0(2): 65-68 |
| |
| Authors: | WANG Wei ZHANG Jie |
| |
| Affiliation: | WANG Wei;ZHANG Jie;Department of Urology, Renmin Hospital of Wuhan University;Huangshi Central Hospital, Hubei Polytechnic University; |
| |
| Abstract: | Renal cell cancer （RCC）is the common malignant in urology. For early stage, the main treatment is radical nephrectomy. However, RCC is insensitive to chemotherapy and radiotherapy in late stage. Major progresses in the treatment of metastatic RCC patients have been made through biological treatment of tumor. This review summarizes recent progress in the clinical research on immune treatment of advanced RCC. |
| |
| Keywords: | renal cell cancer （RCC） immunotherapy targeted therapy vaccine |
| 本文献已被 CNKI 维普 等数据库收录！ |
